Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 195,070 | 108,270 | 52,767 | 83,335 | 19,550 |
| Cost of Goods | 74,012 | 60,090 | 14,845 | 24,625 | 4,058 |
| Gross Profit | 121,058 | 48,180 | 37,922 | 58,710 | 15,492 |
| Operating Expenses | 40,353 | 32,202 | 29,595 | 30,806 | 27,445 |
| Operating Income | 80,717 | 16,068 | 9,172 | 28,529 | -11,895 |
| Interest Expense | 1,679 | 1,676 | 3,109 | 4,712 | 4,805 |
| Other Income | 21,549 | -42,822 | -1,590 | -22,926 | 1,233 |
| Pre-tax Income | 100,587 | -28,430 | 4,473 | 891 | -15,467 |
| Net Income Continuous | 99,779 | -28,430 | 4,473 | 891 | -15,467 |
| Net Income | $99,779 | $-28,430 | $4,473 | $891 | $-15,467 |
| EPS Basic Total Ops | 0.81 | -0.24 | 0.04 | 0.01 | -0.11 |
| EPS Basic Continuous Ops | 0.86 | -0.24 | 0.04 | 0.01 | -0.11 |
| EPS Diluted Total Ops | 0.78 | -0.24 | 0.02 | 0.01 | 0.15 |
| EPS Diluted Continuous Ops | 0.77 | -0.24 | 0.04 | 0.01 | -0.10 |
| EBITDA(a) | $82,510 | $17,906 | $11,089 | $30,509 | $-9,790 |